Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 9;11(3):834.
doi: 10.3390/biomedicines11030834.

Dilated Cardiomyopathy: A Comprehensive Approach to Diagnosis and Risk Stratification

Affiliations
Review

Dilated Cardiomyopathy: A Comprehensive Approach to Diagnosis and Risk Stratification

André Ferreira et al. Biomedicines. .

Abstract

Dilated cardiomyopathy (DCM) represents one of the most common causes of non-ischemic heart failure, characterised by ventricular dilation alongside systolic dysfunction. Despite advances in therapy, DCM mortality rates remain high, and it is one of the leading causes of heart transplantation. It was recently recognised that many patients present minor structural cardiac abnormalities and express different arrhythmogenic phenotypes before overt heart-failure symptoms. This has raised several diagnostic and management challenges, including the differential diagnosis with other phenotypically similar conditions, the identification of patients at increased risk of malignant arrhythmias, and of those who will have a worse response to medical therapy. Recent developments in complementary diagnostic procedures, namely cardiac magnetic resonance and genetic testing, have shed new light on DCM understanding and management. The present review proposes a comprehensive and systematic approach to evaluating DCM, focusing on an improved diagnostic pathway and a structured stratification of arrhythmic risk that incorporates novel imaging modalities and genetic test results, which are critical for guiding clinical decision-making and improving outcomes.

Keywords: arrhythmogenic left ventricle cardiomyopathy; cardiovascular magnetic resonance; dilated cardiomyopathy; genetic testing; reverse remodelling; risk stratification.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Integrated approach for the diagnostic work-up and risk stratification of DCM. Abbreviations; LVEF: left ventricular ejection fraction, CV: cardiovascular, ECG: electrocardiography, ACM: arrhythmogenic cardiomyopathy, DCM: dilated cardiomyopathy, NSVT: non-sustained ventricular tachycardia, PVC: premature ventricular contraction, RV: right ventricle, GLS: global longitudinal strain, LGE: late gadolinium enhancement, ECV: extracellular volume, TTN: Titin, LMNA: Lamin A/C, MYH7: Myosin heavy chain, TNT2: Troponin T, MYBPC3: Myosin binding protein C, PLN: Phospholamban, FLNC: Filamin C, RBM 20: RNA Binding Motif Protein-20.
Figure 2
Figure 2
(I) Case 1 of a patient with a heterozygous variant c.1150G>T, p.(Glu384*) in the LMNA gene [NM_170707.3], classified as pathogenic, exhibiting atrial fibrillation, low QRS voltage, QS morphology in leads V1V3 and two polymorphic ventricular complexes on ECG (A); Echocardiography showing dilated left ventricle (LV) and severely reduced left ventricular ejection fraction (LVEF) (33%) and impaired global longitudinal strain (GLS), average GLS −10.8% (C,E) and cardiovascular magnetic resonance revealing a pattern of laminar intramural late gadolinium enhancement (LGE) in the septum and inferior wall (G). (II) Case 2 of a patient with a heterozygous variant c.54278_54279delCT (p.Pro18093Argfs*5) in the TTN gene [NM_001256850.1], classified as likely pathogenic, showing diffuse ST-T change on ECG (B); Echocardiography presented dilated LV, global hypokinesis and severely impaired LV systolic function (LVEF 12%, GLS -2.8%) (D,F) and no areas of LGE found on CMR (H).

References

    1. Pinto Y.M., Elliott P.M., Arbustini E., Adler Y., Anastasakis A., Böhm M., Duboc D., Gimeno J., de Groote P., Imazio M., et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: A position statement of the ESC working group on myocardial and pericardial diseases. Eur. Heart J. 2016;37:1850–1858. doi: 10.1093/eurheartj/ehv727. - DOI - PubMed
    1. Hershberger R.E., Hedges D.J., Morales A. Dilated cardiomyopathy: The complexity of a diverse genetic architecture. Nat. Rev. Cardiol. 2013;10:531–547. doi: 10.1038/nrcardio.2013.105. - DOI - PubMed
    1. Lund L.H., Edwards L.B., Dipchand A.I., Goldfarb S., Kucheryavaya A.Y., Levvey B.J., Meiser B., Rossano J.W., Yusen R.D., Stehlik J. The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Heart Transplantation Report-2016; Focus Theme: Primary Diagnostic Indications for Transplant. J. Heart Lung Transplant. 2016;35:1158–1169. doi: 10.1016/j.healun.2016.08.017. - DOI - PubMed
    1. Halliday B.P., Gulati A., Ali A., Newsome S., Lota A., Tayal U., Vassiliou V.S., Arzanauskaite M., Izgi C., Krishnathasan K., et al. Sex- and age-based differences in the natural history and outcome of dilated cardiomyopathy. Eur. J. Heart Fail. 2018;20:1392–1400. doi: 10.1002/ejhf.1216. - DOI - PMC - PubMed
    1. Donal E., Delgado V., Bucciarelli-Ducci C., Galli E., Haugaa K.H., Charron P., Voigt J.U., Cardim N., Masci P.G., Galderisi M., et al. Multimodality imaging in the diagnosis, risk stratification, and management of patients with dilated cardiomyopathies: An expert consensus document from the European Association of Cardiovascular Imaging. Eur. Heart J. Cardiovasc. Imaging. 2019;20:1075–1093. doi: 10.1093/ehjci/jez178. - DOI - PubMed

LinkOut - more resources